Comparison of the Efficacy, Safety, Pharmacokinetic and Immunogenicity of UJVIRA (ZRC-3256, Trastuzumab Emtansine) With the Kadcyla (Trastuzumab Emtansine) in the Treatment of HER2-Positive Metastatic Breast Cancer: A Randomized, Open-Label, Multicenter Study in India
| Autor: | Chiradoni Thungappa, Satheesh, Maksud, Tanveer, Raut, Nirmal, Nagarkar, Rajnish, Batra, Ullas, Kumar, Sanjeev, Parmar, Deven |
|---|---|
| Zdroj: | In Clinical Breast Cancer June 2022 22(4):300-307 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect